Certified by Founder
Lodge
C the Signs
start up
United Kingdom
- London
- 31/01/2025
- Unknown
- $8,000,000
C the Signs is a cancer prediction system that can identify patients at risk of cancer at the earliest and most curable stage of the disease.
In under 30 seconds, C the Signs can rapidly identify which cancers a patient is at risk of and recommend the most appropriate test or specialist to diagnose their cancer.
Using the latest technology, research and evidence, C the Signs enables healthcare providers to give their patients the best chance of surviving cancer.
- Industry Hospital & Health Care
- Website https://www.cthesigns.com/
- LinkedIn https://www.linkedin.com/company/c-the-signs/
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)